We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Alexandria Real Estate Equities
ARE
$8.33B
| $10.2M | 0.04% |
86,000
+784
| +0.9% | +$93.4K |
|
352
Coca-Cola Europacific Partners
CCEP
$47.5B
| $10.1M | 0.04% |
128,820
+2,056
| +2% | +$158K |
|
353
Transmedics
TMDX
$3.11B
| $10.1M | 0.04% |
64,400
+55,900
| +658% | +$8.61M |
|
354
Cognizant
CTSH
$26.7B
| $10.1M | 0.04% |
130,810
+2,351
| +2% | +$175K |
|
355
Waters Corp
WAT
$40.6B
| $10.1M | 0.04% |
27,949
-1,264
| -4% | -$412K |
|
356
Datadog
DDOG
$90.6B
| $10M | 0.04% |
87,097
-792
| -0.9% | -$92.5K |
|
357
Illumina
ILMN
$29.1B
| $9.95M | 0.04% |
76,280
+4,558
| +6% | +$562K |
|
358
Hartford Financial Services
HIG
$37.8B
| $9.8M | 0.04% |
83,315
-186
| -0.2% | -$20.4K |
|
359
Reinsurance Group of America
RGA
$16.4B
| $9.59M | 0.04% |
44,000
-56,900
| -56% | -$12.1M |
|
360
Avantor
AVTR
$9.37B
| $9.51M | 0.04% |
367,636
-8,055
| -2% | -$198K |
|
361
CarMax
KMX
$8.52B
| $9.42M | 0.04% |
121,773
-361
| -0.3% | -$28.5K |
|
362
State Street
STT
$52.2B
| $9.06M | 0.04% |
102,433
-15,997
| -14% | -$1.32M |
|
363
MetLife
MET
$61.9B
| $9M | 0.04% |
109,120
+36,367
| +50% | +$2.72M |
|
364
Gartner
IT
$11.6B
| $8.97M | 0.04% |
17,692
+266
| +2% | +$128K |
|
365
Yum! Brands
YUM
$41.2B
| $8.96M | 0.04% |
64,126
+6,668
| +12% | +$886K |
|
366
PACCAR
PCAR
$68.8B
| $8.84M | 0.04% |
89,568
| – | – |
|
|
ALTM
367
DELISTED
Arcadium Lithium plc
ALTM
| $8.73M | 0.03% |
3,064,841
-1,273,042
| -29% | -$3.68M |
|
368
BioMarin Pharmaceuticals
BMRN
$13.3B
| $8.72M | 0.03% |
124,022
+2,456
| +2% | +$205K |
|
369
Ametek
AME
$58.7B
| $8.62M | 0.03% |
50,185
-6,880
| -12% | -$1.15M |
|
370
Super Micro Computer
SMCI
$25.3B
| $8.6M | 0.03% |
206,470
-22,840
| -10% | -$1.39M |
|
371
CoStar Group
CSGP
$13.4B
| $8.58M | 0.03% |
113,696
+2,414
| +2% | +$183K |
|
372
HubSpot
HUBS
$12B
| $8.54M | 0.03% |
16,073
+500
| +3% | +$251K |
|
373
LKQ Corp
LKQ
$6.38B
| $8.54M | 0.03% |
213,836
+7,227
| +3% | +$298K |
|
374
Ares Management
ARES
$33.7B
| $8.4M | 0.03% |
53,881
-2,334
| -4% | -$339K |
|
375
Baxter International
BAX
$14B
| $8.26M | 0.03% |
217,629
+17,450
| +9% | +$641K |
|
Similar funds
GAM
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.